Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Редгіл Байофарма ЛтдfiledCriticalРедгіл Байофарма Лтд
Priority claimed from PCT/IB2012/002252external-prioritypatent/WO2013041963A2/en
Publication of UA112448C2publicationCriticalpatent/UA112448C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems
(AREA)
Abstract
Винахід стосується застосування композиції, що містить кларитроміцин, рифабутин і клофазамін, для виготовлення лікарського засобу для лікування розсіяного склерозу.The invention relates to the use of a composition containing clarithromycin, rifabutin and clofazamine for the manufacture of a medicament for the treatment of multiple sclerosis.
UAA201404226A2011-09-202012-09-19
COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE
UA112448C2
(en)
Antibody to peptide encoded by exon-21 of periostin, and pharmaceutical composition for prevention or treatment of inflammatory disease containing said antibody